CTSA and myeloid sarcoma: Several studies have demonstrated that sera from patient with MS had elevated titers of anti-GSL antibodies, such as anti- GM1 [31], [32], anti-asialo-GM1 [31], anti-GD1a [31], [33], anti-GM3 [34], [35], anti-GD2 [36], anti-GM4 [22], anti-GalCer [22], [37], anti-GQ1b [35], and anti-sulfatide [38].